Earnings call transcript: CVS Health Q4 2024 beats expectations, stock surges
CVS Health Corp (NYSE:CVS) reported a strong finish to 2024, surpassing earnings and revenue forecasts for the fourth quarter. The company posted earnings per share (EPS) of $1.19, beating the ...
Earnings call transcript: Biogen Q4 2024 EPS beats estimates, stock drops
Biogen Inc. (NASDAQ:BIIB), currently valued at $19.15 billion by market capitalization, reported its earnings for the fourth ...